GGrantIndex
Sort

172,184 grants matching inflammation

Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma

$1,122,822
Guido Erwin Michael Eibl · University Of California Los Angeles · P01 · FY2022 · CA

Systemic Inflammation in Microphysiological Models of Muscle and Vascular Disease

$1,122,799
George A Truskey · Duke University · UH3 · FY2020 · TR

Generation of Hematopoietic Stem and Progenitor Cells from Human iPSCs

$1,122,789
Andre Larochelle · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL

Eltrombopag for the Treatment of Fanconi Anemia

$1,122,789
Andre Larochelle · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL

Blended Collaborative Care for Heart Failure and Co-Morbid Depression

$1,122,778
Bruce L Rollman · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · HL

Mechanisms of Rhinovirus-Induced Exacerbations of Asthma

$1,122,692
James E. Gern · University Of Wisconsin-Madison · U19 · FY2006 · AI

Fluorescence Microscopy

$1,122,518
Charles Tucker · National Institute Of Environmental Health Sciences · ZIC · FY2019 · ES

Preterm Epo Neuroprotection Trial (PENUT Trial) CCC

$1,122,470
Sandra E Juul · University Of Washington · U01 · FY2016 · NS

First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial

$1,122,427
Nisha Acharya · University Of California, San Francisco · U10 · FY2015 · EY

Novel approaches to monitoring and utilizing adherence to HIV therapy in Africa

$1,122,416
David Roy Bangsberg · Massachusetts General Hospital · R01 · FY2014 · MH

PEARL: Pathway Exploration and Analysis in Renal Lupus

$1,122,353
Betty Diamond · Feinstein Institute For Medical Research · UH2 · FY2016 · AR

Translational Research in Cystic Fibrosis

$1,122,350
Mitchell L Drumm · Case Western Reserve University · P30 · FY2011 · DK

Translational Research in Cystic Fibrosis

$1,122,350
Mitchell L Drumm · Case Western Reserve University · P30 · FY2010 · DK

Mechanisms of Effective Humoral Immune Responses to HIV-1

$1,122,303
Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Novel Therapies for Alcoholic Hepatitis

$1,122,111
Arthur J McCullough · Cleveland Clinic Lerner Com-Cwru · U01 · FY2012 · AA

Tracking HIV Infection & Alcohol Abuse CNS Comorbidity with Neuroimaging

$1,122,070
Adolf Pfefferbaum · Sri International · U01 · FY2020 · AA

Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy

$1,122,049
Yaron Rotman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK

IND Enabling Studies and Manufacturing Scale Up of Human Placental Extract to Prevent Surgical Necrotizing Enterocolitis

$1,121,897
Michael Bentley Berger · Plakous Therapeutics, Inc. · R44 · FY2024 · HD

The Role of B cells in the Origin and Progression of Multiple Sclerosis

$1,121,140
Stephen L Hauser · University Of California, San Francisco · R35 · FY2020 · NS

Cell Models for AD: Lipids and Related Signaling Pathways

$1,120,946
Grace Y Sun · University Of Missouri-Columbia · P01 · FY2007 · AG

Endocannabinoid Metabolic Enzymes: Structure, Function, In Vivo Inhibition

$1,120,904
Benjamin F Cravatt · Scripps Research Institute, The · P01 · FY2013 · DA

Inflammation and Fibrosis in Pulmonary TB: the INFIN-TB Study

$1,120,842
Sara Auld · Emory University · R01 · FY2023 · AI

Alterations In Pulmonary Immune Function And Host Resistance In COX Null Mice

$1,120,676
Darryl C Zeldin · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES

Emergency Myelopoiesis in the Control of Blood Production

$1,120,635
Emmanuelle Passegue · Columbia University Health Sciences · R35 · FY2025 · HL

Tracking HIV Infection & Alcohol Abuse CNS Comorbidity with Neuroimaging

$1,120,427
Adolf Pfefferbaum · Sri International · U01 · FY2019 · AA